280 related articles for article (PubMed ID: 15827782)
1. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.
Haigh PI; Urbach DR; Rotstein LE
Ann Surg Oncol; 2005 Jan; 12(1):81-9. PubMed ID: 15827782
[TBL] [Abstract][Full Text] [Related]
2. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.
Haigh PI; Urbach DR; Rotstein LE
Surgery; 2004 Sep; 136(3):609-16. PubMed ID: 15349109
[TBL] [Abstract][Full Text] [Related]
3. Predicting outcome and directing therapy for papillary thyroid carcinoma.
Kim S; Wei JP; Braveman JM; Brams DM
Arch Surg; 2004 Apr; 139(4):390-4; discussion 393-4. PubMed ID: 15078706
[TBL] [Abstract][Full Text] [Related]
4. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
5. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
[TBL] [Abstract][Full Text] [Related]
6. Surgery for papillary thyroid carcinoma: is lobectomy enough?
Mendelsohn AH; Elashoff DA; Abemayor E; St John MA
Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1055-61. PubMed ID: 21079156
[TBL] [Abstract][Full Text] [Related]
7. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
9. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
Grigsby PW; Reddy RM; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
[TBL] [Abstract][Full Text] [Related]
10. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
Yildirim E
J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
[TBL] [Abstract][Full Text] [Related]
11. Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy.
Cohn KH; Bäckdahl M; Forsslund G; Auer G; Zetterberg A; Lundell G; Granberg PO; Löwhagen T; Willems JS; Cady B
Surgery; 1984 Dec; 96(6):957-71. PubMed ID: 6505969
[TBL] [Abstract][Full Text] [Related]
12. Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence.
Palmer BA; Zarroug AE; Poley RN; Kollars JP; Moir CR
J Pediatr Surg; 2005 Aug; 40(8):1284-8. PubMed ID: 16080933
[TBL] [Abstract][Full Text] [Related]
13. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
14. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in mortality and morbidity in patients with differentiated thyroid cancer.
Witt RL; McNamara AM
Ear Nose Throat J; 2002 Dec; 81(12):856-63. PubMed ID: 12516384
[TBL] [Abstract][Full Text] [Related]
16. Impact of extensive neck dissection on survival from papillary thyroid cancer.
Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP
ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375
[TBL] [Abstract][Full Text] [Related]
17. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
18. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart.
Haigh PI; Urbach DR
Surgery; 2005 Dec; 138(6):1152-7; discussion 1157-8. PubMed ID: 16360403
[TBL] [Abstract][Full Text] [Related]
19. Predictors of thyroid tumor aggressiveness.
Clark OH
West J Med; 1996 Sep; 165(3):131-8. PubMed ID: 8909165
[TBL] [Abstract][Full Text] [Related]
20. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
